Romano et al., 1999 - Google Patents
Epitope mapping of anti-rhodopsin antibodies from patients with normal pressure glaucoma.Romano et al., 1999
View PDF- Document ID
- 4610478946439038617
- Author
- Romano C
- Li Z
- Arendt A
- Hargrave P
- Wax M
- Publication year
- Publication venue
- Investigative ophthalmology & visual science
External Links
Snippet
PURPOSE: The presence of anti-rhodopsin antibodies in patients with normal pressure glaucoma (NPG) has been previously demonstrated with western blot analysis and enzyme- linked immunosorbent assay. To learn more about the characteristics, origin, and possible …
- 108090001123 antibodies 0 title abstract description 63
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pepys et al. | Human lysozyme gene mutations cause hereditary systemic amyloidosis | |
| Romano et al. | Epitope mapping of anti-rhodopsin antibodies from patients with normal pressure glaucoma. | |
| EP1729792B1 (en) | Y4 selective receptor agonist for therapeutic interventions | |
| US7777001B2 (en) | Agonist polypeptide of receptor for ZOT and zonulin | |
| US20090148466A1 (en) | Process for the Preparation of Hypoallergenic Mosaic Antigens | |
| US6699973B1 (en) | Antibodies to peptides that target GIT receptors and related methods | |
| JP2003511670A (en) | Diagnostic and therapeutic epitopes and transgenic plants | |
| ZA200705031B (en) | Y4 selective receptor agonists for therapeutic interventions | |
| AU3173199A (en) | Novel peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases | |
| US20070161545A1 (en) | Triple polypeptide complexes | |
| US20040152868A1 (en) | Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease | |
| US5958416A (en) | Heat shock protein peptides and methods for modulating autoimmune central nervous system disease | |
| US6210682B1 (en) | Rotavirus enterotoxin NSP4 and methods of using same | |
| AU2005249373A1 (en) | Use of GPCR54 ligands for the treatment of infertility | |
| HUT52787A (en) | Process for production of biologically active peptides | |
| US20060110400A1 (en) | Immunogenic conjugates | |
| Zhu et al. | T cell epitope mapping of ragweed pollen allergen Ambrosia artemisiifolia (Amb a 5) and Ambrosia trifida (Amb t 5) and the role of free sulfhydryl groups in T cell recognition. | |
| KR20070036031A (en) | Corneal Neuron Formation Promoters Containing PAC and Derivatives thereof | |
| CN101602793B (en) | Immunoregulatory polypeptide for preventing and/or treating rheumatoid arthritis and application thereof | |
| IE67318B1 (en) | Biologically active molecules | |
| BR112021000312A2 (en) | VACCINE, PEPTIDES, POLYPEPTIDE, POLYNUCLEOTIDE, VACCINE VECTOR, METHOD OF TREATING OR PREVENTING MAP INFECTION OR THE CONDITION OR SYMPTOM ASSOCIATED WITH MAP AND KIT INFECTION | |
| KR20010006352A (en) | Use of Cartilage Oligomeric Matrix Protein for the Treatment of Rheumatoid Arthritis | |
| JPH11514230A (en) | Pyrosulin 2 | |
| JP2003509336A (en) | New use of substances in PNS | |
| Hargrave | PEPTIDES FROM RHODOPSIN INDUCE EXPERIMENTAL AUTOIMMUNE UVEORETINITIS IN LEWIS RATS |